 Stealth BioTherapeutics Corp Nasdaq: MITO, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy, CEO, will participate in a fireside chat at the virtual BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23 at 3:00 p.m. ET. 